Basking Ridge, NJ, United States of America

Nader Fotouhi

This inventor holds 25 USPTO granted patents and 6 published patent applications and 5 EPO patents, primarily in Antimicrobial Compounds. Top assignees: Hoffmann-La Roche Inc., Global Alliance for Tb Drug Development. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nader Fotouhi. Retrieved from https://idiyas.com/inventor/nader-fotouhi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 6)

% Patents Active = 32.0

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 5.2

ph-index = 8

Forward Citations = 232(Granted Patents)

Location History:

Chatham, NJ (US) (2001 - 2009)
Basking Ridge, NJ (US) (2006 - 2022)
New York, NY (US) (2020 - 2024)

Company Filing History:

22 out of 5,026

Hoffmann-La Roche Inc.

patents

3 out of 10

Global Alliance for Tb Drug Development

patents

Years Active: 2001-2024

Loading Chart...

Areas of Expertise:

Phenyloxazolidinones

Heteroaryltrifluoroborate

Cell Penetrating Peptides

Neuropeptide-2 Receptor

Chiral Imidazolines

MCH Receptor Antagonists

Pyrazolones

Thiazolyl-Benzimidazoles

Substituted Hydantoins

Diaminopropionic Acid

Substituted Pyrroles

Anti-Inflammatory Agents

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11964949 - Substituted phenyloxazolidinones for antimicrobial therapy (2024-04-23),

2. 11261200 - Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections (2022-03-01),

3. 10550092 - Substituted phenyloxazolidinones for antimicrobial therapy (2020-02-04),

4. 9409961 - Cell penetrating peptides to target EIF4E (2016-08-09),

5. 8268784 - Neuropeptide-2 receptor (Y-2R) agonists and uses thereof (2012-09-18),

6. 8093385 - [object Object] (2012-01-10),

7. 7964724 - Chiral cis-imidazolines (2011-06-21),

8. 7803816 - MCH receptor antagonists (2010-09-28),

9. 7728029 - Adamantyl-pyrazole carboxamides as inhibitors of 11β-hdroxysteroid dehydrogenase (2010-06-01),

10. 7705007 - Cis-imidazolines (2010-04-27),

11. 7642244 - Neuropeptide-2 receptor (Y-2R) agonists and uses thereof (2010-01-05),

12. 7622492 - Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase (2009-11-24),

13. 7579368 - Cis-imidazolines (2009-08-25),

14. 7504513 - Thiazolyl-benzimidazoles (2009-03-17),

15. 7491741 - Diaminopropionic acid derivatives (2009-02-17),

Certainly! Here is the article about inventor Nader Fotouhi:

Title: Unveiling the Innovations of Inventor Nader Fotouhi: Pioneering Solutions in Biochemistry

Introduction:

In the vibrant community of Basking Ridge, NJ, inventor Nader Fotouhi has been a beacon of ingenuity and progress. With a remarkable portfolio of 24 patents under his belt, Fotouhi has continually pushed the boundaries of biochemistry and pharmaceuticals.

Latest Patents:

Fotouhi's recent patents showcase his dedication to advancing medical treatments. One of his latest inventions includes the development of Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections, offering new hope in the fight against tuberculosis. Additionally, his work on Substituted phenyloxazolidinones for antimicrobial therapy highlights his commitment to combatting microbial infections.

Career Highlights:

Having contributed to renowned companies like Hoffmann-La Roche Inc., Fotouhi has left an indelible mark on the pharmaceutical industry. His innovative spirit and dedication to research have led to groundbreaking discoveries that have the potential to improve countless lives.

Collaborations:

Throughout his career, Fotouhi has collaborated with esteemed professionals in the field. Notable coworkers such as Paul Gillespie and Sherrie Lynn Pietranico-Cole have been instrumental in shaping his innovative endeavors, fostering a culture of collaboration and excellence.

Conclusion:

Inventor Nader Fotouhi's unwavering passion for innovation and his relentless pursuit of scientific advancement have been instrumental in driving progress in biochemistry. His invaluable contributions continue to inspire and pave the way for a brighter future in the realm of pharmaceuticals and medical research.

Profile summary based on public USPTO records.